NIH-funded research NIH-funded research

Cannabis-based options for diabetic nerve pain in Veterans

Official title: Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain.

Funded at VA Connecticut Healthcare System · NIH-11310852 · Data updated 2026-11-12

This project tests whether cannabis-derived medicines (THC, CBD, or combinations) can help reduce painful diabetic nerve damage in Veterans aged 21 and older.

More Cannabis research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Connecticut Healthcare System
NIH-funded
Lab location1 site (West Haven, United States)
Project startApril 1, 2022
Project endMarch 31, 2027
Funding year2026
NIH project number5I01CX002378-05
Project IDNIH-11310852 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are Veterans aged 21 or older who have chronic diabetic peripheral neuropathy and meet the study's medical and safety criteria.

Less likely to help

People without diabetic neuropathy, those under 21, pregnant people, or individuals with medical or psychiatric conditions that make cannabinoid use unsafe are unlikely to benefit from participating.

What this research studies

You would be invited to join a four-arm clinical trial that compares different cannabis-derived treatments (for example THC, CBD, combinations, or placebo) over a set period. The study enrolls adult Veterans with chronic diabetic peripheral neuropathy and tracks pain levels, side effects, mood, adherence, and biological markers. Visits will include regular check-ins, medication dispensing through VA research pharmacies, and safety monitoring. The goal is to weigh relief and risks to see which option might best help Veterans with this type of nerve pain.

Why it matters

Potential benefit: If successful, this work could identify cannabis-based options that relieve diabetic nerve pain with fewer side effects and potentially reduce reliance on opioids for Veterans.

How similar studies have gone: Prior clinical trials of cannabinoids for neuropathic pain have been small and produced mixed results, so clear benefits remain uncertain.

Where this research is happening

  • VA Connecticut Healthcare System
    West Haven, United States
    Active

Researchers

  • Principal investigator: D'souza, Deepak Cyril — VA Connecticut Healthcare System
  • Study coordinator: D'souza, Deepak Cyril

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.